Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer is Locking in New Growth Through a New Acquisition

Pfizer is undergoing a new acquisition, exposing it to the weight loss market and additional revenue growth potential, which isn't priced in yet.

MarketBeat

Pfizer Faces Court Over Depo-Provera Brain Tumor Claims

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that could determine whether affected women can pursue their cases in court.

Benzinga

Mercosur deal: Von der Leyen being probed for auto-deleting Macron's text

A text message sent by Emmanuel Macron to Ursula von der Leyen is at the centre of an investigation by the European Ombudsman.

Euronews

From analysis to the latest developments in health,
read the most diverse news in one place.

Asian shares trade mixed after US stocks set more records

Asian shares are trading mixed in the absence of key market-driving news in the region, after a seemingly relentless rally continued on Wall Street

The Independent UK

Metsera Stock Rockets After Pfizer's $7.3b — Should You Still Invest?

Metsera stock has soared after Pfizer announced a $7.3 billion acquisition, sparking investor buzz. Analysts are now weighing whether the biotech rally has more room to run or if buyers should stay cautious.

International Business Times UK

Pfizer eyes obesity drug market as it seals $4.9bn deal for Metsera

Pharma giant Pfizer is betting on obesity treatments as it looks for new markets following the success of its COVID-19 vaccine.

Euronews

Pfizer Tries To Revitalize Obesity Portfolio With $5 Billion Matsera Deal

Pfizer Inc. (NYSE:PFE) on Monday agreed to acquire Metsera, Inc. (NASDAQ:MTSR) to accelerate the next generation of medicines for obesity and cardiometabolic diseases.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Pfizer amps up push into obesity treatments with $4.9B deal for Metsera

Pfizer is doubling down on obesity treatments by spending $4.9 billion on the development-stage drugmaker Metsera

The Independent UK

Why the Recovery in Pfizer Stock Could Be Bigger Than Investors Expect

Pfizer is quietly laying the foundation for a new era of sustainable growth.

Barchart

Pfizer Reportedly Nears Metsera Acquisition Deal: PFE Stock Climbs In Monday Pre-Market

Pfizer Inc. (NYSE:PFE) stock climbed 1.54% in Monday pre-market amid reports that the company on the verge of acquiring Metsera Inc. (NASDAQ:MTSR), a developer of anti-obesity drugs.

Benzinga

The 5 Best Dividend Stocks to Buy for Steady Income in 2025

Here are five “set-and-forget” dividend stocks.

Barchart

Blue Chip Stocks With Fat Dividends: Smart Buy Or Value Trap?

Investors love blue-chip stocks that pay fat dividends, but high yield alone doesn’t guarantee a safe income stream.

Benzinga

Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump administration health officials intend to link the vaccines to 25 child deaths. This assertion is reportedly based on unverified submissions to the Vaccine…

Benzinga

Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) reported topline Phase 3 results for their LP.8.1-adapted monovalent COMIRNATY (2025-2026 Formula) in high-risk adults.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

We risk a deluge of AI-written ‘science’ pushing corporate interests – here’s what to do about it

Back in the 2000s, the American pharmaceutical firm Wyeth was sued by thousands of women who had developed breast cancer after taking its hormone replacement drugs. Court filings revealed the role of “dozens of ghostwritten reviews and commentaries published in medical journals and supplements being used to promote unproven benefits…

We Got This Covered

Donald Trump undermines his one lonely success that is apparently his one-way ticket to the Nobel Peace Prize

Looks like he is running out of things to destroy.

Benzinga

Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster' (CORRECTED)

Editor’s Note: This article has been updated to reflect the correct year-to-date performance of Moderna stock.

The Independent UK

Pfizer CEO is latest to say Trump should get Nobel Peace Prize – for something much of MAGA hates

Vaccine makers are publicly defending Covid-era achievements as the Trump administration rolls back vaccine approvals and cuts research funding

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

What you need to know about Covid vaccines in the US this fall

In a move praised by RFK Jr, the FDA approved a new shot, but only for some people – here’s what to know about who can get them, and where

We Got This Covered

‘I want it NOW’: Trump wants ‘justifications’, rich coming from a guy who’s spent his entire career dodging them

He wants proof.

Barchart

Is Pfizer Stock Underperforming the Nasdaq?

Although Pfizer has underperformed the Nasdaq recently, analysts remain moderately optimistic about the stock’s prospects.

Benzinga

Trump Demands Pfizer, Other Covid Drug Makers To 'Justify The Success,' Show Their Results Amid New FDA Restrictions

President Donald Trump has called for pharmaceutical companies to provide evidence of the effectiveness of their COVID-19 drugs.

Benzinga

Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works

Former Centers for Disease Control and Prevention immunizations chief Demetre Daskalakis said Sunday he resigned because politics has overrun science at the nation's top public-health agency, warning he "only see[s] harm coming" under Health and Human Services Secretary Robert F. Kennedy Jr.

Al Jazeera

Who can get updated COVID-19 vaccines in the US now?

FDA has approved COVID shots for people aged 65+ and at high risk; others need a doctor’s order.

The Guardian - US

RFK Jr faces calls to quit as CDC chief fired and senior staff resign: ‘an embarrassment’

Susan Monarez’s ousting and four top resignations follow vaccine confusion, leaving US health agencies in turmoil

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Centers for Disease Control and Prevention

320 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.